18F-FDG-PET-CT in patients with differentiated thyroid carcinoma, elevated thyroglobulin and negative 131I scan

被引:0
|
作者
Mendez, D. R. [1 ]
Rodado, S. [1 ]
Santos, I. [1 ]
Hernandez, I. [1 ]
Couto, R. [1 ]
Marin, M. [1 ]
Coronado, M. [1 ]
Martin Curto, L. [1 ]
机构
[1] Univ Hosp La Paz, Madrid, Spain
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
P0934
引用
收藏
页码:S563 / S563
页数:1
相关论文
共 50 条
  • [31] 18F-FDG PET in the Management of Differentiated Thyroid Cancer in Patients with High Serum Thyroglobulin and Negative I-131 Whole Body Scan.
    Martins, R. G.
    Santos, A. P.
    Couto, J.
    Barbosa, A. P.
    Teixeira, J.
    Lucena, I.
    Bastos, L.
    Torres, I.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [32] Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas
    Giovanella, Luca
    Ceriani, Luca
    De Palma, Diego
    Suriano, Sergio
    Castellani, Massimo
    Verburg, Frederik A.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (05): : 626 - 631
  • [33] Response to the letter to the editor "18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I"
    Albano, Domenico
    Tulchinsky, Mark
    Bertagna, Francesco
    Giubbini, Raffaele
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 2952 - 2953
  • [34] Response to the letter to the editor “18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I”
    Domenico Albano
    Mark Tulchinsky
    Francesco Bertagna
    Raffaele Giubbini
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2952 - 2953
  • [35] Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan
    Martin, M. N. Cabrera
    Pingarron, J. A. Pasamontes
    Delgado, J. L. Carreras
    Gutierrez, Lapena
    Bolton, R. C. Delgado
    Copano, A. Bimni
    Castejon, M. J. Perez
    Perez, C. Fernandez
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2007, 26 (05): : 263 - 269
  • [36] 68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum Thyroglobulin
    Binse, Ina
    Poeppel, Thorsten D.
    Ruhlmann, Marcus
    Ezziddin, Samer
    Goerges, Rainer
    Sabet, Amir
    Beiderwellen, Karsten
    Bockisch, Andreas
    Rosenbaum-Krumme, Sandra J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (10) : 1512 - 1517
  • [37] Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
    Min Liu
    Lingxiao Cheng
    Yuchen Jin
    Maomei Ruan
    Shiwei Sheng
    Libo Chen
    [J]. Scientific Reports, 8
  • [38] Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin
    Liu, Min
    Cheng, Lingxiao
    Jin, Yuchen
    Ruan, Maomei
    Sheng, Shiwei
    Chen, Libo
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [39] Clinical value of 18F-FDG PET/CT in postoperative differentiated thyroid cancer patients with elevated thyroglobulin
    Pan, Liqin
    Ouyang, Wei
    Feng, Huijuan
    Yuan, Liyi
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Wang, Jing
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [40] 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative I-131 Whole Body Scan. It's Value Confirmed by a Bicentric Experience
    Bertagna, Francesco
    Albano, Domenico
    Bosio, Giovanni
    Piccardo, Arnoldo
    Dib, Bassam
    Giubbini, Raffaele
    [J]. CURRENT RADIOPHARMACEUTICALS, 2016, 9 (03) : 228 - 234